About SciLicium
Bioinformatics for scientists,
not just bioinformaticians
SciLicium started in 2020 in Rennes. The founding team was bioinformaticians, biologists, and data scientists who kept running into the same problem: the people generating biological data and the scientists trying to interpret it had almost no overlap. We built tools to close that gap.
Today we work with R&D teams in cosmetics, pharma, and biotech. OmicSkin handles transcriptomics for safety and efficacy studies. SkinMAP is a single-cell atlas of human skin. TOXsIgN covers toxicogenomics. GenoLens brings it all into one place. None of it requires an in-house bioinformatician.
Our Mission
Bioinformatics that works
for the scientist, not the other way around
We measure success with one question: can an R&D team go from raw omics data to results they can act on, without needing a bioinformatician on staff? If yes, we did our job. The scientific rigour has to hold up either way.
Scientific integrity
We don't cut corners on statistical methods. Every analysis follows established methodology, and we document everything.
Innovation
Bioinformatics tools age fast. We stay current with the field and rebuild things when better approaches exist.
Collaboration
The best work we do comes from staying close to the scientists using our tools. We treat that feedback seriously.
Data-driven
Our recommendations come from statistics, not intuition. When the data does not support a conclusion, we say so.
Our Journey
From prototype to platform
SciLicium is founded in Rennes by a small team of bioinformaticians and biologists. The first client projects are in cosmetics transcriptomics.
SciLicium is founded in Rennes by a small team of bioinformaticians and biologists. The first client projects are in cosmetics transcriptomics.
The French government grants SciLicium its Crédit d'Impôt Recherche certification, confirming its R&D status.
The French government grants SciLicium its Crédit d'Impôt Recherche certification, confirming its R&D status.
OmicSkin launches. A transcriptomics platform built for cosmetic safety and efficacy studies, now open to research partners.
OmicSkin launches. A transcriptomics platform built for cosmetic safety and efficacy studies, now open to research partners.
SkinMAP opens to research partners. A single-cell atlas of human skin built to speed up cell type discovery.
SkinMAP opens to research partners. A single-cell atlas of human skin built to speed up cell type discovery.
GenoLens is in active development. An accessible visualisation and analysis platform extending our tools across the full omics pipeline.
GenoLens is in active development. An accessible visualisation and analysis platform extending our tools across the full omics pipeline.
The Team
Built by researchers, for researchers
Everyone on the team has a scientific background. Most have PhDs. They come from bioinformatics, biology, data science, and project management.
Our bioinformaticians handle transcriptomics, metagenomics, and multi-omics pipelines. Most have PhDs and active research experience.
Our data scientists build the statistical models and machine learning layers that take raw results and make them readable.
Having biologists in the room keeps the analysis grounded. They catch things that look statistically fine but make no biological sense.
Our project managers own timelines and client communication so the scientists can focus on the science.
We're growing the team.
See open positionsRecognition
Credentials & scientific output
Get in touch
Want to know more about SciLicium?
If you're a potential customer, partner, investor, or researcher, we'd love to talk.